Cibc Private Wealth Group, LLC Beam Therapeutics Inc. Transaction History
Cibc Private Wealth Group, LLC
- $52.7 Billion
- Q4 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,981 shares of BEAM stock, worth $46,157. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,981
Previous 2,345
15.52%
Holding current value
$46,157
Previous $57,000
14.04%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BEAM
# of Institutions
253Shares Held
78.6MCall Options Held
304KPut Options Held
142K-
Farallon Capital Management LLC San Francisco, CA8.24MShares$192 Million1.09% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$178 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.62MShares$178 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.07MShares$165 Million1.53% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.54MShares$106 Million70.85% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.64B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...